Digital assistant aims to close gaps in hereditary cancer care
NCT ID NCT06914726
First seen Jul 10, 2026 ยท Last updated Jul 10, 2026
Summary
This trial tests a digital tool that helps doctors and patients manage cancer risks linked to hereditary syndromes like BRCA-related breast/ovarian cancer and Lynch syndrome. The tool provides personalized recommendations during primary care visits. Researchers compare care gaps, shared decision-making, and patient confidence between those using the tool and those receiving usual care.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Patient-centered clinical decision support (PC-CDS) tool
- What this could lead to
- If successful, this tool could help people with hereditary cancer syndromes get the right preventive care and make informed decisions about their health.
- What could go wrong
- This is a behavioral intervention study, not a drug trial. The tool may not change care patterns or improve outcomes as hoped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENETIC VARIATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
HealthPartners Medical Group
Minneapolis, Minnesota, 55440, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a walking routine alter cancer biomarkers? new trial investigates
- Lynch syndrome patients share colonoscopy struggles in new survey
- Can a registry help more families get tested for cancer genes?
- Personalized vaccine aims to stop lynch syndrome cancers before they start
- Swiss study aims to find hidden cancer genes in families
- Could lynch syndrome raise your risk of gum disease?